Wealth Enhancement Advisory Services
RCEL icon

Wealth Enhancement Advisory Services’s Avita Medical RCEL Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,181
Closed -$148K – 3465
2025
Q1 		$148K Buy
18,181
+2,564
+16% +$24K ﹤0.01% 2689
2024
Q4 		$200K Sell
15,617
-588
-4% -$6.93K ﹤0.01% 2695
2024
Q3 		$174K Buy
16,205
+56
+0.3% +$526 ﹤0.01% 2476
2024
Q2 		$128K Buy
+16,149
New +$154K ﹤0.01% 2371

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Wealth Enhancement Advisory Services's RCEL Position: Q2 2025 in Review

Wealth Enhancement Advisory Services sold out of Avita Medical (RCEL) in Q2 2025, closing a stake of 18,181 shares — an estimated $148K sold.

Wealth Enhancement Advisory Services first reported a position in RCEL in Q2 2024 and held it in 4 quarters. The position peaked at $200K in Q4 2024. 80 funds tracked by Wall St. Rank hold RCEL as of Q2 2025.

  • Wealth Enhancement Advisory Services reported no remaining Avita Medical position as of Q2 2025 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 18,181 Avita Medical shares in Q2 2025, an estimated $148K.
  • Wealth Enhancement Advisory Services first reported a position in Avita Medical in Q2 2024 and held it in 4 quarters.
  • Wealth Enhancement Advisory Services's Avita Medical position peaked at $200K in Q4 2024.
  • 80 funds tracked by Wall St. Rank held Avita Medical as of Q2 2025.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2025, filed 10 Jul 2025.